Press Release, PRnob.com, July 30th, 2015, United Kingdom : Based on previous findings, Valtrex Generic was said to have efficacy to combat HIV-1 only if the patient’s body was affected by another infection. However, the researches recently may have got a breakthrough wherein the medicine can prevent multiplication of HIV virus even without an existent infection. Thus, there is a possibility that the product can treat a variety of patients with HIV-1 and further developments can be studied to devise an ultimate and permanent cure for the disease.
Generally, patients buy Valacyclovir to treat genital herpes. But, now with studies conveying that the medicine could even significantly reduce HIV-1, the sales could shoot up, if a relevant potent medicine is developed by the scientists. This product builds resistance against the HIV virus and helps lessen its effect on immune system. People are waiting for a scientific magic to work, which can slash down deaths caused by AIDS. This could be the greatest victory in the history of medical science.
As per the associate professor and senior author of Medicine and Infectious Diseases in Case Western Reserve University School of Medicine in the U.S, Benigno Rodriguez that the antiviral drugs of this type fights HIV without the HSV-2 presence as well. This herpes virus treatment medicine showed decreased HIV-1 presence in tests conducted on patients. The experiment noted results that instilled hope in doctors who are researching on the cause for more than a decade.
The mechanism of Valtrex Generic activates the infected cells by virus by blocking HIV from multiplication. However, if the same reproduces, then it can be dangerous for immune system, leading to AIDS, which does not yet have a cure. Previously, this herpes virus treatment only showed positive outcomes on patients with HSV-2 that activated immune system leaving lesser immune cells for attachment so that HIV-1 was prohibited from spreading further.
Another of antiviral drugs, Acyclovir was studied by Leonid Margolis from National Institutes of Health. He concluded that the ingredient did stop spread of HIV-1 despite the non-presence of HSV-2 in the patient. This experiment has urged many researched to look deeply into this herpes virus treatment like never before for a greater healing option. Investment in these Valtrex Generic has already increased after the reports were published.
There is a higher scope of patients hounding the market to buy Valacyclovir as well. In 2009, from the Lima region of Peru, a similar study was taken ahead by University Hospitals Case Medical Centre and IMPACTA. The efforts went until July 2012, where it was joined in by The Civic Association for Health and Education. Half of the participants were kept on placebo, while the others were given these antiviral drugs. After medication intake, two weeks of the research, the process went vice-versa.
The participants who were given placebos were administered the medicine and those who had taken the same, were told not to take the pill. The outcome was surprising, as those who were provided the medicine showed lesser amount of HIV in tests, while those on placebos HIV level sprung up. According to the research’s senior author, Michael M Lederman, the confirmation was given that if patients of HIV buy Valacyclovir for intake, the medicine may block replication of HIV without the requirement of herpes simplex virus 2.
Contact-
Harvey Dobson
+44 -079 0044 7473
